Search

for
Search:

Glossary Verteporfin

Verteporfin is a photosensitizing agent primarily used in photodynamic therapy for certain medical conditions, including age-related macular degeneration. In the context of hair loss, it has been studied for its potential to enhance hair regrowth by promoting vascularization and cellular activity in hair follicles when activated by light. Key distinguishing characteristics of verteporfin include its ability to selectively target abnormal cells and its mechanism of action that involves generating reactive oxygen species upon light activation, which may stimulate hair follicle activity.

Related Terms

Learn

2 / 801 results

learn Verteporfin

chemical that might completely regrow follicles from hair transplant extractions

What is Verteporfin, and why is it being studied for hair follicle regeneration? Verteporfin is being studied for hair follicle regeneration due to its ability to inhibit YAP, promoting tissue healing.
Can Verteporfin reduce scarring in alopecia or improve hair regrowth after hair transplant surgery? Verteporfin currently lacks clinical evidence for reducing scarring or improving hair regrowth.
Is Verteporfin used as a topical treatment, injection, or oral medication for hair loss? Verteporfin is an intravenous drug approved only for an eye condition; it is not approved for hair loss in any form. In the few published hair reports it was injected into the scalp alongside surgical wounding — unverified case reports of one and two patients, not trial evidence.
All 5 questions on Verteporfin →

learn PENTAVITIN®

View more "verteporfin" in learn →

Research

5 / 61 results

research Use of Verteporfin with Dermal Wounding to Regenerate New Hair in Androgenetic Alopecia

September 2025 in “Journal of Dermatology Research and Therapy”

In this study, two male patients with androgenetic alopecia who had previously undergone hair transplants showed increased hair regrowth after receiving verteporfin injections, with a 63% mean increase in dense donor sites, 38% in thinning areas, but no growth in bald areas.

research Use of Verteporfin to Regrow Hair and Reduce Fibrosis after Transplantation

July 2025 in “Journal of Dermatology Research and Therapy”

In this Stanford study, verteporfin was used to promote scarless skin regeneration by inhibiting YAP activity in a 27-year-old female, resulting in increased hair density at the treated site compared to the untreated control.

Inhibition of the Hippo Pathway by Verteporfin Reduces the Proliferation and Stemness of Rat Hair Follicle Neural Crest Stem Cells Under Hypoxia

research Inhibition of the Hippo pathway by verteporfin reduces the proliferation and stemness of rat hair follicle neural crest stem cells under hypoxia

February 2025 in “FASEB BioAdvances”

In this study, hypoxic conditions were found to enhance stemness in hair follicle neural crest stem cells, while inhibiting the Hippo pathway significantly decreased their proliferation.

research Fibroblasts – the cellular choreographers of wound healing

74 citations , August 2023 in “Frontiers in Immunology”

In this review, the authors explored the diverse roles of fibroblasts in wound healing, suggesting that understanding their complexity could lead to better insights into wound pathologies and the development of new treatments.

research Current Therapeutic Approaches to Chronic Central Serous Chorioretinopathy

13 citations , February 2019 in “Türk oftalmoloji dergisi”

This review discusses various treatment options for chronic central serous chorioretinopathy, evaluating studies conducted since 2000, but reports no new clinical results.

View more "verteporfin" in research →

Community Join

5 / 100 results

community Verteporfin and KY19382 experiment

80 upvotes 2 weeks ago

The conversation discusses an experiment involving hair loss treatments, including the use of Verteporfin, KY19382, dutasteride, oral and topical minoxidil, AHK-Cu, and microneedling. The experiment aims to test the effectiveness of these treatments in promoting hair growth and healing without scarring, with updates planned every few months.

community So the cure for Nw7 is verteporfin

7 upvotes 1 month ago

Verteporfin, used with dermal incisions by doctors like Dr. Melissa Toyos, is suggested as a promising treatment for high Norwood hair loss, with some users reporting significant regrowth. However, there is skepticism about its effectiveness due to concurrent use of other treatments like dutasteride and oral minoxidil.

community What happened with verteporfin?

30 upvotes 1 month ago

Verteporfin, combined with microneedling, shows promise for hair regrowth by allowing hair follicles to grow in wounds, but it's expensive and painful. Pai-1 inhibitors may also help prevent hair loss by degrading fibrosis, and some users continue using minoxidil alongside these treatments.

community New Preprint: Retinoic Acid Supports Verteporfin-Induced Regeneration

17 upvotes 2 months ago

Verteporfin followed by retinoic acid improves wound regeneration in mini-pigs. Retinoic acid does not significantly enhance regeneration in rabbits.

community Any new Verteporfin updates?? Does anyone have any new information on the trials?

6 upvotes 2 months ago

Verteporfin updates for hair loss and its trials. Users also express interest in exosomes.

View more "verteporfin" in community →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →